Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis

Neuroscience

Volumn 118, Issue 2, 2003, Pages 359-369

  Anderson, E R ^a   Boyle, J ^a   Zink, W E ^a   Persidsky, Y ^a   Gendelman, H E ^a   Xiong, H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CA1; Excitatory postsynaptic potential; HIV 1 associated dementia; Monocyte derived macrophages; SCID mice

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; ENCEPHALITIS; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 0037426575     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00925-9     Document Type: Article

References (52)

1. Avgeropoulos N., Kelley B., Middaugh L., Arrigo S., Persidsky Y., Gendelman H.E., Tyor W.R. SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol. 18:1998;13-20.
2. Bagetta G., Corasaniti M.T., Costa N., Berliocchi L., Finazzi-Agro A., Nistico G. The human immunodeficiency virus type 1 (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat. Neurosci Lett. 224:1997;75-78.
3. Bellinger F.P., Madamba S., Siggins G.R. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:1993;227-234.
4. Bliss T.V.P., Collingridge G.L. A synaptic model of memory long-term potentiation in the hippocampus . Nature. 361:1993;31-39.
5. Brenneman D.E., McCune S.K., Mervis R.F., Hill J.M. gp120 as an etiologic agent for NeuroAIDS neurotoxicity and model systems . Adv Neuroimmunol. 4:1994;157-165.
6. Burudi E.M., Fox H.S. Simian immunodeficiency virus model of HIV-induced central nervous system dysfunction. Adv Virus Res. 56:2001;435-468.
7. Carpenter C.C., Cooper D.A., Fischl M.A., Gatell J.M., Gazzard B.G., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S., Richman D.D., Saag M.S., Schechter M., Schooley R.T., Thompson M.A., Vella S., Yeni P.G., Volberding P.A. Antiretroviral therapy in adults updated recommendations of the International AIDS Society-USA Panel . JAMA. 283:2000;381-390.
8. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA. 95:1998;3117-3121.
9. Cotter R., Zheng J., Gendelman H.E. The role of mononuclear phagocytes in neurodegenerative disorders: lessons from multiple sclerosis, Alzheimer's disease and HIV-1 dementia. Marwah J., Teitelbaum H. Advances in neurodegenerative disorders. 1999;203-241 Prominent Press, Scottsdale, AZ. Vol 2.
10. Cotter R.L., Burke W.J., Thomas V.S., Potter J.F., Zheng J., Gendelman H.E. Insights into the neurodegenerative process of Alzheimer's disease a role for mononuclear phagocyte-associated inflammation and neurotoxicity . J Leukoc Biol. 65:1999;416-427.
11. Cunningham A.L., Naif H., Saksena N., Lynch G., Chang J., Li S., Jozwiak R., Alali M., Wang B., Fear W., Sloane A., Pemberton L., Brew B. HIV infection of macrophages and pathogenesis of AIDS dementia complex interaction of the host cell and viral genotype. J Leukoc Biol. 62:1997;117-125.
12. Desbaillets I., Tada M., de Tribolet N., Diserens A.C., Hamou M.F., Van Meir E.G. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer. 58:1994;240-247.
13. Desrosiers R.C., Hansen-Moosa A., Mori K., Bouvier D.P., King N.W., Daniel M.D., Ringler D.J. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am J Pathol. 139:1991;29-35.
14. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
15. Epstein L.G., Sharer L.R., Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol. 23:1988;S19-23.
16. Everall I.P., Luthert P.J., Lantos P.L. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337:1991;1119-1121.
17. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., Burke D.S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 167:1988;1428-1441.
18. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am J Hum Genet. 65:1999;13-18.
19. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain correlations with dementia . Ann Neurol. 38:1995;755-762.
20. Glass J.D., Wesselingh S.L., Selnes O.A., McArthur J.C. Clinical neuropathologic correlation in HIV-associated dementia. Neurology. 43:1993;2230-2237.
21. Hill J.M., Mervis R.F., Avidor R., Moody T.W., Brenneman D.E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603:1993;222-233.
22. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA. 96:1999;3228-3233.
23. Janssen R.S., Nwanyanwu O.C., Selik R.M., Stehr-Green J.K. Epidemiology of HIV encephalopathy in the United States. Neurology. 42:1992;1472-1476.
24. Janssen R.S., Saykin A.J., Cannon L., Campbell J., Pinsky P.F., Hessol N.A., O'Malley P.M., Lifson A.R., Doll L.S., Rutherford G.W., Kaplan J.E. Neurological and neuropsychological manifestations of HIV-1 infection association with AIDS-related complex but not asymptomatic HIV-1 infection . Ann Neurol. 26:1989;592-600.
25. Kalter D.C., Nakamura J.A., Turpin J.A., Baca L.M., Hoover D.L., Dieffenbach C., Ralph P., Gendelman H.E., Meltzer M.S. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol. 146:1991;298-306.
26. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:2001;988-994.
27. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA. 96:1999;8212-8216.
28. Krebs F.C., Ross H., McAllister J., Wigdahl B. HIV-1-associated central nervous system dysfunction. Adv Pharmacol. 49:2000;315-385.
29. Krucker T., Toggas S., Mucke L., Siggins S. Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus. Neuroscience. 83:1998;691-700.
30. Larson J., Lynch G., Games D., Seubert P. Alterations in synaptic ansmission and n-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840:1999;23-35.
31. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 16:1995;934-940.
32. Masliah E., Achim C.L., Ge N., DeTeresa R., Terry R.D., Wiley C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol. 32:1992;321-329.
33. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., Jacobson L.P., Visscher B.R., Concha M., Saah A. Dementia in AIDS patients incidence and risk factors: Multicenter AIDS Cohort Study. Neurology. 43:1993;2245-2252.
34. McArthur J.C., Sacktor N., Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol. 19:1999;129-150.
35. Nathanson N. Towards an AIDS vaccine the role of primate models . Int J STD AIDS. 9:1998;3-7.
36. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex I. Clinical features . Ann Neurol. 19:1986;517-524.
37. Orenstein J.M., Fox C., Wahl S.M. Macrophage as a source of HIV during opportunistic infections. Science. 276:1997;1857-1861.
38. Persidsky Y. Model systems for studies of leukocyte migration across the blood-brain barrier. J Neurovirol. 5:1999;579-590.
39. Persidsky Y., Gendelman H.E. Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia. J Leukoc Biol. 62:1997;100-106.
40. Persidsky Y., Ghorpade A., Rasmussen J., Limoges J., Liu X.J., Stins M., Fiala M., Way D., Kim K.S., Witte M.H., Weinand M., Carhart L., Gendelman H.E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol. 155:1999;1599-1611.
41. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H.S., Epstein L., Gelbard H., Flanagan E., Reinhard J., Pirruccello S.J., Gendelman H.E. Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol. 149:1996;1027-1053.
42. Sacktor N., Lyles R.H., Skolasky R., Kleeberger C., Selnes O.A., Miller E.N., Becker J.T., Cohen B., McArthur J.C. HIV-associated neurologic disease incidence changes Multicenter AIDS Cohort Study, 1990-1998 . Neurology. 56:2001;257-260.
43. Saitoh T., Kang D., Mallory M., DeTeresa R., Masliah E. Glial cells in Alzheimer's disease preferential effect of APOE risk on scattered microglia . Gerontology. 43:1997;109-118.
44. Sanchez-Alavez M., Criado J., Gomez-Chavarin M., Jimenez-Anguiano A., Navarro L., Diaz-Ruiz O., Galicia O., Sanchez-Narvaez F., Murillo-Rodriguez E., Henriksen S.J., Elder J.H., Prospero-Garcia O. HIV- and FIV-derived gp120 alter spatial memory, LTP, and sleep in rats. Neurobiol Dis. 7:2000;384-394.
45. Seabrook G.R., Easter A., Dawson G.R., Bowery B.J. Modulation of long-term potentiation in CA1 region of mouse hippocampal brain slices by GABA A receptor benzodiazepine site ligands. Neuropharmacology. 36:1997;823-830.
46. Steigerwald E.S., Sarter M., March P., Podell M. Effects of feline immunodeficiency virus on cognition and behavioral function in cats. J Acquir Immune Defic Syndr Hum Retrovirol. 20:1999;411-419.
47. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol. 58:1999;233-247.
48. Wiley C.A., Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 36:1994;673-676.
49. Xiong H., Baskys A., Wojtowicz J.M. Brain-derived peptides inhibits synaptic transmission via GABAB receptors in CA1 area of rats. Brain Res. 737:1996;188-194.
50. Xiong H., Zeng Y.C., Zheng J., Thylin M., Gendelman H.E. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation a mechanism for cognitive dysfunction in HIV-1-associated dementia. J NeuroVirol. 5:1999;519-528.
51. Zheng J., Ghorpade A., Niemann D., Cotter R.L., Thylin M.R., Epstein L., Swartz J.M., Shepard R.B., Liu X., Nukuna A., Gendelman H.E. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis implications for human immunodeficiency virus type 1-associated dementia. J Virol. 73:1999;8256-8267.
52. Zink M.C., Amedee A.M., Mankowski J.L., Craig L., Didier P., Carter D.L., Munoz A., Murphey-Corb M., Clements J.E. Pathogenesis of SIV encephalitis. Am J Pathol. 151:1997;793-803.